U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Product Details

Additional Information about Patents

  • Patent information is published on or after the submission date as defined in 21 CFR 314.53(d)(5).
  • Patent listings published prior to August 18, 2003, only identify method-of-use claims. The listed patents may include drug substance and/or drug product claims that are not indicated in the listing.
  • As of December 5, 2016, an NDA holder submitting information on a patent that claims both the drug substance and the drug product (and is eligible for listing on either basis) is required only to specify that it claims either the drug substance or the drug product. Orange Book users should not rely on an Orange Book patent listing, regardless of when first published, to determine the range of patent claims that may be asserted by an NDA holder or patent owner.

Patent and Exclusivity for: N022192

Product 001
ILOPERIDONE (FANAPT) TABLET 1MG

Patent Data

Product No Patent No Patent Expiration Drug Substance Drug Product Patent Use Code Delist Requested Submission Date
001 8586610 11/02/2027 U-1625 01/08/2015
001 8652776 08/31/2030 U-1685 04/30/2015
001 8999638 10/28/2030 U-1674 04/07/2015
001 9072742 01/16/2031 U-1674 07/28/2015
001 9074254 12/28/2031 U-1674 07/28/2015
001 9074255 12/17/2030 U-1674 07/28/2015
001 9074256 02/10/2031 U-1674 07/28/2015
001 9138432 09/30/2025 U-1737 09/22/2015
001 9157121 04/05/2030 U-1674 10/13/2015

Exclusivity Data

Product No Exclusivity Code Exclusivity Expiration
001 I-939 04/02/2027

 

 


View a list of all patent use codes
View a list of all exclusivity codes

Back to Top